Ocular Therapeutix Inc.
OCUL | NASDAQ
$6.75
-$0.22 (-3.16%)
Nov 2, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -301.45M | -290.5M | -265.94M | -249.67M | -216.75M | -192.71M | -193.51M | -174.34M | -138.36M | -115.27M | -80.74M | -67.06M | -90.73M | -88.81M | -71.04M | -59.35M | -32.5M | -22.22M | -6.55M | -88.32M | -102.92M | -131M |
Depreciation & Amortization | 5.45M | 4.63M | 4.32M | 4.03M | 3.92M | 3.85M | 3.79M | 3.79M | 3.72M | 3.42M | 2.98M | 2.52M | 2.14M | 2.04M | 2.11M | 2.19M | 2.27M | 2.33M | 2.42M | 2.52M | 2.59M | 2.69M |
Stock-Based Compensation | 53.28M | 48.31M | 43.18M | 39.02M | 33.97M | 35.59M | 33.11M | 30.24M | 28.11M | 21.23M | 17.83M | 17.73M | 17.46M | 17.33M | 16.96M | 16.57M | 16.09M | 16.1M | 14.98M | 13.24M | 11.42M | 8.95M |
Other Working Capital | -3.03M | -90K | 7.38M | 11.71M | 4.26M | 9.68M | -2.97M | -11.07M | -7.12M | -13.44M | -2.81M | 2.7M | 2.36M | 1.21M | 2.88M | 2.16M | 3.63M | 3.02M | 4.24M | 15.02M | 14M | 13.95M |
Other Non-Cash Items | 6.85M | 8.22M | 5.84M | 5.89M | -2.77M | -492K | 32.16M | 40.24M | 22.68M | 20.33M | -6.95M | -18.99M | 7.39M | 4.57M | -8.99M | -19.67M | -44.7M | -55.38M | -48.48M | -32.66M | -12.63M | 727K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.13M | -1.13M | -1.13M | -1.13M | n/a | n/a | n/a | n/a | n/a | -25.02M | 44.53M | 44.53M | 61.54M |
Change in Working Capital | -2.37M | 3.14M | 7.71M | 10.67M | 5.73M | 8.31M | -10.23M | -17.64M | -10.21M | -17.92M | -7.41M | -2.99M | -5.3M | 3.9M | 1.35M | 2.45M | 1.23M | -7.63M | -2.9M | 4.04M | -316K | 5.04M |
Operating Cash Flow | -238.24M | -226.21M | -204.88M | -190.06M | -175.9M | -145.46M | -134.68M | -117.7M | -94.06M | -89.33M | -75.42M | -69.92M | -70.18M | -60.98M | -59.6M | -57.8M | -57.61M | -66.79M | -65.55M | -56.64M | -57.32M | -52.06M |
Capital Expenditures | -16.86M | -14.74M | -12.01M | -9.37M | -3.47M | -2.97M | -1.29M | -1.55M | -1.72M | -2.96M | -6.09M | -7.78M | -8.31M | -6.82M | -3.72M | -2.2M | -1.68M | -1.31M | -1.19M | -816K | -754K | -750K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 130K | 130K | 130K | 130K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -16.86M | -14.61M | -11.88M | -9.24M | -3.34M | -2.97M | -1.29M | -1.55M | -1.72M | -2.96M | -6.09M | -7.78M | -8.31M | -6.82M | -3.72M | -2.2M | -1.68M | -1.31M | -1.19M | -816K | -754K | -750K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.13M | -26.13M | -26.13M | -26.13M | n/a | n/a | n/a | n/a | n/a | 1.64M | -445K | -445K | -445K | -2.08M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -275K | -275K | -275K | -275K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 4.18M | 8.17M | 12.35M | 14.05M | 14.74M | 11.19M | 89.49M | 88.61M | 83.81M | 83.83M | 1.73M | 1.4M | 1.45M | 996K | 1.3M | 1.84M | 1.71M | 3.65M | 3.5M | 3.2M |
Financial Cash Flow | 462.61M | 557.83M | 561.72M | 116.86M | 110.68M | 15.07M | 332.11M | 435.77M | 488.71M | 496.16M | 175.01M | 67.3M | 10.56M | 1.4M | 1.45M | 1.66M | 1.97M | 4.14M | 2.85M | 166.1M | 165.64M | 214.03M |
Net Cash Flow | 207.51M | 317.02M | 344.96M | -82.45M | -68.56M | -133.36M | 196.15M | 316.52M | 392.93M | 403.86M | 93.51M | -10.4M | -67.93M | -66.39M | -61.86M | -58.33M | -57.32M | -63.96M | -63.89M | 108.64M | 107.57M | 161.23M |
Free Cash Flow | -255.1M | -240.94M | -216.89M | -199.44M | -179.37M | -148.43M | -135.97M | -119.25M | -95.77M | -92.3M | -81.51M | -77.7M | -78.49M | -67.79M | -63.32M | -59.99M | -59.29M | -68.1M | -66.74M | -57.46M | -58.07M | -52.81M |
Adj. Free Cash Flow | -308.38M | -289.25M | -260.08M | -238.46M | -213.34M | -184.01M | -169.07M | -149.49M | -123.89M | -113.53M | -99.33M | -95.43M | -95.95M | -85.12M | -80.28M | -76.57M | -75.38M | -84.2M | -81.72M | -70.7M | -69.49M | -61.76M |
Maintenance CapEx | -11.97M | -11.36M | -12.01M | -9.17M | -3.18M | -2.13M | -198.69K | -254.57K | -254.57K | -424.56K | -3.7M | -4.57M | -5.37M | -5.12M | -1.84M | -910.86K | -116.86K | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -4.9M | -3.38M | n/a | -202K | -291K | -834.32K | -1.09M | -1.29M | -1.46M | -2.54M | -2.39M | -3.2M | -2.94M | -1.7M | -1.87M | -1.29M | -1.56M | -1.31M | -1.19M | -816K | -754K | -750K |
Owner Earnings | -250.21M | -237.57M | -216.89M | -199.23M | -179.08M | -147.59M | -134.88M | -117.96M | -94.31M | -89.76M | -79.12M | -74.5M | -75.54M | -66.09M | -61.44M | -58.71M | -57.73M | -66.79M | -65.55M | -56.64M | -57.32M | -52.06M |
Add to Watchlist
Select watchlists to add or remove OCUL